As of 2026-02-25, the EV/EBITDA ratio of Medexus Pharmaceuticals Inc (MDP.TO) is 4.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MDP.TO's latest enterprise value is 102.45 mil CAD. MDP.TO's TTM EBITDA according to its financial statements is 23.03 mil CAD. Dividing these 2 quantities gives us the above MDP.TO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 14.2x | 10.3x |
| Forward P/E multiples | 10.7x - 16.4x | 10.9x |
| Fair Price | 3.93 - 9.75 | 5.51 |
| Upside | 38.4% - 243.4% | 94.1% |
| Date | EV/EBITDA |
| 2026-02-23 | 4.45 |
| 2026-02-20 | 4.52 |
| 2026-02-19 | 4.48 |
| 2026-02-18 | 4.46 |
| 2026-02-17 | 4.48 |
| 2026-02-13 | 4.48 |
| 2026-02-12 | 4.31 |
| 2026-02-11 | 4.41 |
| 2026-02-10 | 4.45 |
| 2026-02-09 | 4.46 |
| 2026-02-06 | 4.45 |
| 2026-02-05 | 4.45 |
| 2026-02-04 | 4.46 |
| 2026-02-03 | 4.52 |
| 2026-02-02 | 4.46 |
| 2026-01-30 | 4.43 |
| 2026-01-29 | 4.48 |
| 2026-01-28 | 4.45 |
| 2026-01-27 | 4.53 |
| 2026-01-26 | 4.58 |
| 2026-01-23 | 4.49 |
| 2026-01-22 | 4.45 |
| 2026-01-21 | 4.42 |
| 2026-01-20 | 4.39 |
| 2026-01-19 | 4.45 |
| 2026-01-16 | 4.41 |
| 2026-01-15 | 4.32 |
| 2026-01-14 | 4.46 |
| 2026-01-13 | 4.52 |
| 2026-01-12 | 4.60 |
| 2026-01-09 | 4.51 |
| 2026-01-08 | 4.67 |
| 2026-01-07 | 4.52 |
| 2026-01-06 | 4.65 |
| 2026-01-05 | 4.63 |
| 2026-01-02 | 4.80 |
| 2025-12-31 | 4.55 |
| 2025-12-30 | 4.60 |
| 2025-12-29 | 4.63 |
| 2025-12-24 | 4.35 |
| 2025-12-23 | 4.38 |
| 2025-12-22 | 4.31 |
| 2025-12-19 | 4.20 |
| 2025-12-18 | 4.20 |
| 2025-12-17 | 4.18 |
| 2025-12-16 | 4.18 |
| 2025-12-15 | 4.24 |
| 2025-12-12 | 4.13 |
| 2025-12-11 | 4.17 |
| 2025-12-10 | 4.14 |